MethylDetect –
Your Source for DNA Methylation Assays

DNA Methylation is one of the most widely studied epigenetic mechanisms of gene expression regulation. Aberrant methylation of increasing number of genes is being shown to contribute to the majority of diseases from cancer, inflammatory, autoimmune and metabolic diseases through environmental related diseases to psychiatric disorders.

Solid research evidence already shows that DNA methylation-based biomarkers can be utilized at all stages of clinical disease management including:

  • Disease risk assessment
  • Early detection
  • Personalization of treatment
  • Monitoring of chronic disorders and recurrence

MethylDetect offers ready-to-use kits for detection of aberrant gene methylation. The kits are based on the MS-HRM (Methylation Sensitive High Resolution Melting) technology and can be used with standard laboratory equipment. Additionally, our new controls system shipped with each kit, provides state-of-the-art experimental reliability.

Learn More About MS-HRM Here>>>

3 weeks ago
Association of MGMT Promoter Methylation Status With Survival Outcomes in Glioma https://t.co/JKyf0Pkazy
1 month ago
Interesting paper:

"MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?"

https://t.co/FsIANCXJWE